Voloridge Investment Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,588
| Closed | -$431K | – | 1564 |
|
|
2023
Q2 | $431K | Sell |
15,588
-449,735
| -97% | -$12.4M | ﹤0.01% | 1252 |
|
|
2023
Q1 | $10.7M | Buy |
465,323
+297,954
| +178% | +$6.85M | 0.05% | 437 |
|
|
2022
Q4 | $1.83M | Sell |
167,369
-259,024
| -61% | -$2.83M | 0.01% | 986 |
|
|
2022
Q3 | $3.59M | Sell |
426,393
-170,094
| -29% | -$1.43M | 0.02% | 768 |
|
|
2022
Q2 | $4.72M | Buy |
596,487
+519,886
| +679% | +$4.11M | 0.02% | 701 |
|
|
2022
Q1 | $1.81M | Sell |
76,601
-107,047
| -58% | -$2.53M | 0.01% | 988 |
|
|
2021
Q4 | $6.28M | Sell |
183,648
-366,435
| -67% | -$12.5M | 0.03% | 631 |
|
|
2021
Q3 | $9.75M | Buy |
550,083
+543,579
| +8,358% | +$9.63M | 0.06% | 441 |
|
|
2021
Q2 | $292K | Buy |
+6,504
| New | +$292K | ﹤0.01% | 1522 |
|